Nufabrx Completes Oversubscribed $10 Million Series A Round
Retrieved on:
Thursday, October 14, 2021
Conover, North Carolina, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Nufabrx, a drug delivery platform dedicated to simplifying patients ability to receive the benefits of medication through everyday clothing, announced the closing of an oversubscribed $10 million Series A funding round.
Key Points:
- Conover, North Carolina, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Nufabrx, a drug delivery platform dedicated to simplifying patients ability to receive the benefits of medication through everyday clothing, announced the closing of an oversubscribed $10 million Series A funding round.
- Strategic investments were also received from previous investors such as the Charlotte Angel Fund and North Carolina State University Wolfpack Fund.
- We are excited to partner with the team at Nufabrx to realize its full clinical and commercial potential.
- Founded in 2011, Nufabrx was created by Founder Jordan Schindler after discovering his pillowcase was contributing to his acne.